Company Filing History:
Years Active: 2011-2024
Title: Mark B Zimering: Innovator in Serotonin Receptor Research
Introduction
Mark B Zimering is a notable inventor based in Lyons, NJ (US). He has made significant contributions to the field of neuroscience, particularly in the study of serotonin receptors. With a total of 3 patents, his work focuses on innovative methods to inhibit the binding of autoantibodies to serotonin receptors.
Latest Patents
Zimering's latest patents include compositions and methods aimed at inhibiting the binding of plasma IgG autoantibodies to the serotonin 2A receptor. These patents disclose decoy peptides or polypeptides that can effectively inhibit the binding of 5-HT2A autoantibodies to a specific extracellular loop region of the 5-HT2A receptor. Additionally, these patents detail pharmaceutical compositions containing these decoy peptides or polypeptides and their methods of use.
Career Highlights
Mark B Zimering is currently associated with the United States Government as represented by the Department of Veterans Affairs. His work has been instrumental in advancing the understanding of serotonin receptor interactions and their implications in various medical conditions.
Collaborations
Zimering has collaborated with notable colleagues such as Zui Pan and Janet Alder, contributing to a rich environment of research and innovation.
Conclusion
Mark B Zimering's contributions to the field of serotonin receptor research highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing new therapeutic strategies that could benefit many individuals.